Cabaletta Bio, Inc

(NASDAQ:CABA)

Latest On Cabaletta Bio, Inc (CABA):

Date/Time Type Description Signal Details
2023-05-18 16:00 ESTNewsCabaletta Bio up 1%, prices $87M offeringN/A
2023-05-18 02:29 ESTNewsCabaletta Bio commences underwritten public offering of sharesN/A
2023-05-16 23:33 ESTNewsCabaletta Bio jumps 16% as FDA clears trial for myositis candidateN/A
2023-05-11 15:27 ESTNewsCabaletta Bio GAAP EPS of -$0.45 beats by $0.02N/A
2023-05-01 18:20 ESTNewsCabaletta's potential lupus drug CABA-201 gets FDA fast track tagN/A
2023-04-28 03:16 ESTNewsCabaletta Bio: Speculative Biotech With OpportunityN/A
2023-03-31 16:02 ESTNewsCabaletta CAR T cell therapy for lupus gets FDA nod to enter trialN/A
2023-03-31 16:02 ESTNews4 stocks to watch on Friday: Amazon, Kraft Heinz, and moreN/A
2023-03-16 13:19 ESTNewsCabaletta Bio GAAP EPS of -$0.52 misses by $0.08N/A
2023-01-27 17:59 ESTNewsCabaletta rises as Morgan Stanley upgrades citing new CAR-T assetN/A
2023-01-25 12:46 ESTNewsCabaletta: Adding To Position For 36% Return Potential After CABA-201 Rally (Technical Analysis)N/A
2022-12-08 20:30 ESTNewsCabaletta Bio dips on announcing $35M offeringN/A
2022-11-10 11:40 ESTNewsCabaletta Bio GAAP EPS of -$0.39 beats by $0.09N/A
2022-08-30 16:03 ESTNewsCabaletta downgraded at Morgan Stanley on upcoming data for lead assetN/A
2022-08-11 21:46 ESTNewsCabaletta Bio GAAP EPS of -$0.45 beats by $0.05N/A
2022-05-18 20:14 ESTNewsCabaletta Bio updates Phase 1 interim data for lead assetN/A
2022-05-12 11:04 ESTNewsCabaletta Bio GAAP EPS of -$0.45N/A
2022-03-18 09:46 ESTNewsCabaletta Bio GAAP EPS of -$0.49 beats by $0.11N/A
2021-12-14 08:41 ESTNewsCabaletta Bio tanks 34% on cell therapy data in early-stage study for pemphigus vulgarisN/A
2021-11-01 14:01 ESTNewsCabaletta Bio EPS beats by $0.05N/A
2021-11-01 14:01 ESTNewsCabaletta rises as skin diseases drug shown to be safe in early data of phase 1 trialN/A
2021-08-19 00:00 ESTNewsCabaletta Bio reports results from DesCAARTes trial in patients with pemphigus vulgarisN/A
2021-08-05 20:25 ESTNewsCabaletta Bio EPS beats by $0.03N/A
2021-03-18 15:25 ESTAnalyst RatingThe Analyst Target Price has increased from $20.33 to $22.25.Buy
2021-03-18 07:46 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 17:01 ESTNewsCabaletta Bio EPS misses by $0.04N/A
2021-03-17 15:39 ESTEarnings EstimateAn EPS average of -$0.46 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-17 15:39 ESTEarnings EstimateAn EPS average of -$2.18 is estimated for the 2022 year.Sell
2021-01-20 12:58 ESTNewsCabaletta: DSG3-CAART's 1H 2021 Data Release Can Substantiate This Young BiotechN/A
2021-01-11 10:22 ESTAnalyst RatingThe Analyst Target Price has increased from $20 to $20.33.Buy
2021-01-09 03:37 ESTNewsChardan Capital initiates Cabaletta Bio with Buy ratingN/A
2020-12-10 06:47 ESTNewsDosing underway in Cabaletta Bio's DSG3-CAART study in a rare skin blistering disorderN/A
2020-12-04 06:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 00:46 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 15:51 ESTAnalyst RatingThe Analyst Target Price has decreased from $21.67 to $20.Neutral
2020-11-17 07:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 23:46 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 07:15 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 09:52 ESTNewsCabaletta Bio EPS beats by $0.08N/A
2020-11-11 09:52 ESTNewsCabaletta Bio +5% on Q3 results, pipeline updateN/A
2020-11-11 06:54 ESTEarnings EstimateAn EPS average of -$0.44 is estimated for the quarter ending on March 31, 2021.Sell
2020-10-15 08:02 ESTNewsCabaletta Bio (CABA) Investor Presentation - SlideshowN/A
2020-10-14 11:22 ESTAnalyst RatingThe Analyst Target Price has decreased from $22.5 to $21.67.Neutral
2020-10-08 21:07 ESTFinancialsCompany financials have been released.Neutral
2020-10-04 15:25 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 16:38 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 09:18 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 12:44 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 03:29 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 23:40 ESTFinancialsCompany financials have been released.Neutral

About Cabaletta Bio, Inc (CABA):

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also include MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. Cabaletta Bio, Inc. has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was founded in 2017 and is headquartered in Philadelphia, Pennsylvania.

CABA Quotes by TradingView

See Advanced Chart

General

  • Name Cabaletta Bio, Inc
  • Symbol CABA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 31
  • Fiscal Year EndDecember
  • IPO Date2019-10-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.cabalettabio.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.23
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.13
  • Next Year EPS Estimate -$2.45
  • Next Quarter EPS Estimate -$0.42
  • Return on Assets -17%
  • Return on Equity -27%
  • Earnings Per Share -$0.94
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 276.24 million
  • Analyst Target Price $22.25
View More

Share Statistics

  • Shares Outstanding 24.06 million
  • Shares Float 7.91 million
  • % Held by Insiders 523%
  • % Held by Institutions 67.4%
  • Shares Short 1.63 million
  • Shares Short Prior Month 1.61 million
  • Short Ratio 15.52
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • 52 Week High $16.38
  • 52 Week Low $6.07
  • 50 Day Moving Average 11.96
  • 200 Day Moving Average 12.4
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Cabaletta Bio, Inc (CABA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Cabaletta Bio, Inc (CABA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-16$N/A-$0.40-$0.36-11.11%
2020-09-302020-11-10$N/A-$0.36-$0.4418.18%
2020-06-302020-08-06$N/A-$0.35-$0.3910.26%
2020-03-312020-05-12$N/A-$0.33-$0.23-43.48%
2019-12-312020-03-30$N/A-$0.33-$0.4729.79%
2019-09-302019-12-05$N/A-$1.21-$2.2646.46%

Cabaletta Bio, Inc (CABA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Cabaletta Bio, Inc (CABA) Chart:

Cabaletta Bio, Inc (CABA) News:

Below you will find a list of latest news for Cabaletta Bio, Inc (CABA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Cabaletta Bio, Inc (CABA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-06-180.50CALL0 10TRUE00
2026-06-1810CALL0 00TRUE00
2026-06-181.50CALL0 10TRUE00
2026-06-1821.05CALL20 90277.3TRUE1.050
2026-06-182.50.5CALL10 55211.93TRUE0.030.06
2026-06-1830.11CALL56 70549.27TRUE-0.09-0.45
2026-06-183.50.08CALL299 1367224.69FALSE-0.01-0.11
2026-06-1840.03CALL11 2285172.06FALSE00
2026-06-184.50CALL0 956262.12FALSE00
2026-06-1850CALL0 849398.38FALSE00
2026-06-185.50CALL0 1354516.11FALSE00
2026-06-187.50CALL0 3576.06FALSE00
2026-06-180.50PUT0 6932.18FALSE00
2026-06-1810PUT0 1894.15FALSE00
2026-06-181.50PUT0 2385.85FALSE00
2026-06-1820PUT0 7247.14FALSE00
2026-06-182.50PUT0 250197.26FALSE00
2026-06-1830PUT0 382111FALSE00
2026-06-183.50.55PUT18 802149.68TRUE00
2026-06-1841PUT3 60144.64TRUE00
2026-06-184.50PUT0 24189.96TRUE00
2026-06-1850PUT0 10325.07TRUE00
2026-06-185.50PUT0 0262.37TRUE00
2026-06-187.50PUT0 00TRUE00
2026-07-170.50CALL0 00TRUE00
2026-07-1710CALL0 0242.87TRUE00
2026-07-171.51.52CALL0 33204.87TRUE00
2026-07-1720CALL0 310TRUE00
2026-07-172.50.55CALL20 47107.51TRUE0.550
2026-07-1730.25CALL79 52586.41TRUE-0.2-0.44
2026-07-173.50.19CALL9 71192.82FALSE-0.03-0.14
2026-07-1740.15CALL3 110299.43FALSE00
2026-07-174.50CALL0 43158.12FALSE00
2026-07-1750.05CALL0 321233.28FALSE00
2026-07-175.50CALL0 13146.74FALSE00
2026-07-177.50CALL0 13347.03FALSE00
2026-07-170.50PUT0 6559.86FALSE00
2026-07-1710.25PUT1 3343.65FALSE00
2026-07-171.50PUT0 0447.6FALSE00
2026-07-1720PUT0 3114.75FALSE00
2026-07-172.50PUT0 0122.77FALSE00
2026-07-1730.3PUT0 16140.52FALSE00
2026-07-173.50.7PUT2 278105.97TRUE0.050.08
2026-07-1741.2PUT10 131115.5TRUE1.20
2026-07-174.50PUT0 2165.35TRUE00
2026-07-1750PUT0 3187.11TRUE00
2026-07-175.50PUT0 0205.79TRUE00
2026-07-177.50PUT0 0221.56TRUE00
2026-08-210.52.66CALL0 290TRUE00
2026-08-2110CALL0 0167.04TRUE00
2026-08-211.50CALL0 450TRUE00
2026-08-2121.2CALL20 41128.19TRUE0.050.04
2026-08-212.50.73CALL6 26037110.38TRUE0.730
2026-08-2130CALL0 3885133.62TRUE00
2026-08-213.50CALL0 112127.82FALSE00
2026-08-2140.15CALL2 84123.24FALSE0.150
2026-08-214.50CALL0 48171.9FALSE00
2026-08-2150.28CALL0 387113.05FALSE00
2026-08-215.50CALL0 9211.77FALSE00
2026-08-217.50CALL0 920243.16FALSE00
2026-08-210.50.03PUT7 9261.92FALSE0.030
2026-08-2110PUT0 0468.2FALSE00
2026-08-211.50PUT0 0315.23FALSE00
2026-08-2120PUT0 0224.46FALSE00
2026-08-212.50PUT0 371110.77FALSE00
2026-08-2130PUT0 107119.48FALSE00
2026-08-213.50PUT0 0124.29TRUE00
2026-08-2140PUT0 42129.86TRUE00
2026-08-214.50PUT0 10118.26TRUE00
2026-08-2152.19PUT0 19155.58TRUE00
2026-08-215.50PUT0 0121.8TRUE00
2026-08-217.50PUT0 0187.78TRUE00
2026-09-180.52.6CALL0 300TRUE00
2026-09-1810CALL0 36234.24TRUE00
2026-09-181.50CALL0 9088.93TRUE00
2026-09-1820CALL0 60992.76TRUE00
2026-09-182.50CALL0 6778107.18TRUE00
2026-09-1830CALL0 3638116.4TRUE00
2026-09-183.50CALL0 402107.35FALSE00
2026-09-1840.5CALL0 130128.13FALSE00
2026-09-184.50CALL0 65140.52FALSE00
2026-09-1850CALL0 354133.01FALSE00
2026-09-185.50CALL0 51148.8FALSE00
2026-09-187.50CALL0 972213.24FALSE00
2026-09-180.50PUT0 150FALSE00
2026-09-1810PUT0 0395.75FALSE00
2026-09-181.50PUT0 1266.54FALSE00
2026-09-1820PUT0 0189.92FALSE00
2026-09-182.50PUT0 40133.27FALSE00
2026-09-1830PUT0 48118.37FALSE00
2026-09-183.50PUT0 7113.79TRUE00
2026-09-1840PUT0 37110.61TRUE00
2026-09-184.50PUT0 1118.85TRUE00
2026-09-1850PUT0 8123.75TRUE00
2026-09-185.50PUT0 0161.94TRUE00
2026-09-187.50PUT0 0137.79TRUE00
2026-11-200.52.62CALL0 30TRUE00
2026-11-2010CALL0 140TRUE00
2026-11-201.50CALL0 0135.38TRUE00
2026-11-2020CALL0 27102.36TRUE00
2026-11-202.50CALL0 321156.41TRUE00
2026-11-2030CALL0 41106.4TRUE00
2026-11-203.50CALL0 44114.46FALSE00
2026-11-2040CALL0 44111.63FALSE00
2026-11-204.50CALL0 7111.94FALSE00
2026-11-2050.55CALL0 32122.64FALSE00
2026-11-205.50CALL0 892138.22FALSE00
2026-11-207.50CALL0 0158.93FALSE00
2026-11-200.50PUT0 100FALSE00
2026-11-2010PUT0 0309.69FALSE00
2026-11-201.50PUT0 1208.73FALSE00
2026-11-2020PUT0 1158.6FALSE00
2026-11-202.50PUT0 245112.54FALSE00
2026-11-2030PUT0 10127.34FALSE00
2026-11-203.50PUT0 0115.58TRUE00
2026-11-2040PUT0 0107.05TRUE00
2026-11-204.50PUT0 20114.25TRUE00
2026-11-2050PUT0 0125.57TRUE00
2026-11-205.50PUT0 0128.8TRUE00
2026-11-207.50PUT0 0111.64TRUE00
2027-01-150.52.66CALL0 200TRUE00
2027-01-1512.12CALL41 16125.66TRUE0.070.03
2027-01-151.50CALL0 229115.11TRUE00
2027-01-1520CALL0 132112.25TRUE00
2027-01-152.50CALL0 555119.96TRUE00
2027-01-1530CALL0 908129.8TRUE00
2027-01-153.50CALL0 50137.63FALSE00
2027-01-1540.8CALL0 192122.71FALSE00
2027-01-154.50CALL0 26122.9FALSE00
2027-01-1550.75CALL44 1837134.93FALSE0.750
2027-01-155.50.55CALL0 165159.22FALSE00
2027-01-157.50CALL0 10136.34FALSE00
2027-01-150.50PUT0 90FALSE00
2027-01-1510PUT0 0267.85FALSE00
2027-01-151.50PUT0 12180.66FALSE00
2027-01-1520PUT0 256137.47FALSE00
2027-01-152.50PUT0 255128.28FALSE00
2027-01-1530PUT0 16122.88FALSE00
2027-01-153.50PUT0 60123.32TRUE00
2027-01-1540PUT0 50126.47TRUE00
2027-01-154.50PUT0 2127.34TRUE00
2027-01-1552.5PUT0 19126.49TRUE00
2027-01-155.50PUT0 50124.21TRUE00
2027-01-157.50PUT0 200127.19TRUE00
2028-01-210.52.65CALL41 215122.19TRUE-0.2-0.07
2028-01-2112.5CALL1 9110.01TRUE2.50
2028-01-211.50CALL0 96129.1TRUE00
2028-01-2120CALL0 40176.97TRUE00
2028-01-212.52.01CALL0 396122.14TRUE00
2028-01-2131.7CALL22 468151.04TRUE-0.2-0.11
2028-01-213.50CALL0 93137.07FALSE00
2028-01-2140CALL0 232139.62FALSE00
2028-01-214.50CALL0 13133.02FALSE00
2028-01-2151.45CALL5 185130.41FALSE1.450
2028-01-215.51.5CALL0 270135.01FALSE00
2028-01-210.50PUT0 11170.51FALSE00
2028-01-2110PUT0 0167.45FALSE00
2028-01-211.50PUT0 0120.5FALSE00
2028-01-2120PUT0 20119.56FALSE00
2028-01-212.50PUT0 44101.83FALSE00
2028-01-2130PUT0 807107.03FALSE00
2028-01-213.50PUT0 38135TRUE00
2028-01-2140PUT0 20135TRUE00
2028-01-214.50PUT0 15142.43TRUE00
2028-01-2150PUT0 85140.8TRUE00
2028-01-215.50PUT0 2138.78TRUE00

Latest CABA Trades:

Date Shares Price
Jun 13, 2022 7:37 PM EST1$1.08
Jun 13, 2022 7:37 PM EST6$1.08
Jun 13, 2022 7:51 PM EST7$1.06
Jun 13, 2022 7:57 PM EST7$1.06
Jun 13, 2022 7:58 PM EST7$1.055

Cabaletta Bio, Inc (CABA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520159049/0001193125-20-159049-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025941/0000899243-19-025941-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025942/0000899243-19-025942-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025943/0000899243-19-025943-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025946/0000899243-19-025946-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025947/0000899243-19-025947-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026016/0000899243-19-026016-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026017/0000899243-19-026017-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026018/0000899243-19-026018-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026020/0000899243-19-026020-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026345/0000899243-19-026345-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026346/0000899243-19-026346-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320004509/0000899243-20-004509-index.htm
2020-02-135Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320004511/0000899243-20-004511-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320006864/0000899243-20-006864-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320006865/0000899243-20-006865-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320006867/0000899243-20-006867-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320025326/0000899243-20-025326-index.htm
2020-07-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000090266420002724/0000902664-20-002724-index.htm
2019-11-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000092963819000988/0000929638-19-000988-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000092963820000331/0000929638-20-000331-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000110465919056233/0001104659-19-056233-index.htm
2019-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000110465919057348/0001104659-19-057348-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000110465919058504/0001104659-19-058504-index.htm
2019-11-12SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759138/000110465919061822/0001104659-19-061822-index.htm
2019-10-24S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1759138/000119312519273939/0001193125-19-273939-index.htm
2019-10-25424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1759138/000119312519274807/0001193125-19-274807-index.htm
2019-10-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1759138/000119312519277804/0001193125-19-277804-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312519278927/0001193125-19-278927-index.htm
2019-11-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000119312519287367/0001193125-19-287367-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520005110/0001193125-20-005110-index.htm
2020-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520017724/0001193125-20-017724-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000119312520038349/0001193125-20-038349-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520042689/0001193125-20-042689-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520090013/0001193125-20-090013-index.htm
2020-03-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1759138/000119312520091086/0001193125-20-091086-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1759138/000119312520115863/0001193125-20-115863-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520134391/0001193125-20-134391-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520139782/0001193125-20-139782-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520153792/0001193125-20-153792-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520159049/0001193125-20-159049-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520211336/0001193125-20-211336-index.htm
2019-10-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000119380519001374/0001193805-19-001374-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000119380519001376/0001193805-19-001376-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000119380520000185/0001193805-20-000185-index.htm
2019-12-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759138/000156459019045375/0001564590-19-045375-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1759138/000156459020013929/0001564590-20-013929-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759138/000156459020024508/0001564590-20-024508-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759138/000156459020037278/0001564590-20-037278-index.htm
2019-10-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1759138/999999999519002384/9999999995-19-002384-index.htm

Cabaletta Bio, Inc (CABA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cabaletta Bio, Inc (CABA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 523%
Institutional Ownership: 6740%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-10-295AM Ventures V, L.P.10% Share HolderBuy454,545.0011.004,999,995.00454,545.00https://www.sec.gov/Archives/edgar/data/1759138/000110465919058504/0001104659-19-058504-index.htm
2019-10-29James E Flynn10% Share HolderBuy700,000.0011.007,700,000.00700,000.00https://www.sec.gov/Archives/edgar/data/1759138/000119380519001376/0001193805-19-001376-index.htm